Abstract
We conducted a search for rare, functional variants altering susceptibility to Alzheimer's disease that exploited knowledge of common variants associated with the same disease. We found that loss-of-function variants in ABCA7 confer risk of Alzheimer's disease in Icelanders (odds ratio (OR) = 2.12, P = 2.2 × 10−13) and discovered that the association replicated in study groups from Europe and the United States (combined OR = 2.03, P = 6.8 × 10−15).
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Saunders, A.M. et al. Neurology 43, 1467–1472 (1993).
Strittmatter, W.J. et al. Proc. Natl. Acad. Sci. USA 90, 1977–1981 (1993).
Cruts, M., Theuns, J. & Van Broeckhoven, C. Hum. Mutat. 33, 1340–1344 (2012).
Guerreiro, R. et al. N. Engl. J. Med. 368, 117–127 (2013).
Jonsson, T. et al. Nature 488, 96–99 (2012).
Jonsson, T. et al. N. Engl. J. Med. 368, 107–116 (2013).
Lambert, J.C. et al. Nat. Genet. 45, 1452–1458 (2013).
Kong, A. et al. Nat. Genet. 40, 1068–1075 (2008).
Wu, M.C. et al. Am. J. Hum. Genet. 89, 82–93 (2011).
Kim, W.S., Weickert, C.S. & Garner, B. J. Neurochem. 104, 1145–1166 (2008).
Abe-Dohmae, S. et al. J. Biol. Chem. 279, 604–611 (2004).
Wang, N. et al. J. Biol. Chem. 278, 42906–42912 (2003).
Iwamoto, N., Abe-Dohmae, S., Sato, R. & Yokoyama, S. J. Lipid Res. 47, 1915–1927 (2006).
Jehle, A.W. et al. J. Cell Biol. 174, 547–556 (2006).
Kim, W.S. et al. J. Biol. Chem. 280, 3989–3995 (2005).
Kim, W.S. et al. J. Neurosci. 33, 4387–4394 (2013).
Griciuc, A. et al. Neuron 78, 631–643 (2013).
Takahashi, K., Rochford, C.D. & Neumann, H. J. Exp. Med. 201, 647–657 (2005).
Allen, M. et al. Neurology 79, 221–228 (2012).
Vasquez, J.B., Fardo, D.W. & Estus, S. Neurosci. Lett. 556, 58–62 (2013).
McKhann, G. et al. Neurology 34, 939–944 (1984).
World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines (World Health Organization, 1992).
McKhann, G.M. et al. Alzheimers Dement. 7, 263–269 (2011).
Magnus, P. et al. Int. J. Epidemiol. 35, 1146–1150 (2006).
Natunen, T. et al. J. Alzheimers Dis. 37, 217–232 (2013).
Styrkarsdottir, U. et al. Nature 497, 517–520 (2013).
McLaren, W. et al. Bioinformatics 26, 2069–2070 (2010).
Adzhubei, I.A. et al. Nat. Methods 7, 248–249 (2010).
Devlin, B. & Roeder, K. Biometrics 55, 997–1004 (1999).
Acknowledgements
This work was done in collaboration with Illumina. The authors are grateful to the participants and their relatives. We also thank the staff and researchers at the Krókháls recruitment center, the Memory Clinic at the National Hospital of Iceland and the deCODE Genetics core facilities. This work was carried out with support from the Academy of Finland; EVO grant 5772708 of Kuopio University Hospital; the Strategic Funding of the University on Eastern Finland (University of Eastern Finland–Brain); the Sigrid Juselius Foundation; Framework Programme 7, grant agreement 601055; VPH Dementia Research Enabled by IT VPH-DARE@IT; the Research Council of Norway (223273, 225989, 237250/EU JPND); the K.G. Jebsen Foundation; the Norwegian Health Association; the AXA Research Fund, the Fondation Université Pierre et Marie Curie and the Fondation pour la Recherche sur Alzheimer, Paris, France; and the program 'Investissements d'Avenir' ANR-10-IAIHU-06.
Author information
Authors and Affiliations
Consortia
Contributions
S.S., H. Stefansson, T.J. and K.S. designed the study. S.S., H.J., A.I., H. Helgason, P.S., S.A.G., A.K. and U.U. carried out data analysis. O.T.M. performed experiments. S.H., H. Soininen, M.H., DemGene, D.A., T.F., I.D.U., S.D., S.B.S., L.R.W., G.-P.K., L.T.W., G.S., O.A.A., J.J.L., A.I.L., I.G., H. Hampel, D.R., P.V.J., S.B. and J.S. diagnosed and recruited patients. S.S., H. Stefansson, T.J. and K.S. wrote the manuscript with the support of the remaining authors.
Corresponding author
Ethics declarations
Competing interests
S.S., H. Stefansson, T.J., H.J., A.I., H. Helgason, P.S., O.T.M., S.A.G., U.U., A.K. and K.S. are employed by deCODE Genetics/Amgen.
Integrated supplementary information
Supplementary Figure 1 ABCA7 transcripts at the exon 41 border in a c.5570+5G>C carrier and a c.5570+5G>C non-carrier.
Coordinates are NCBI Build 36. The c.5570+5G>C carrier and non-carrier are shown in the upper and lower panels, respectively.
Supplementary information
Supplementary Text and Figures
Supplementary Figure 1, Supplementary Note and Supplementary Tables 1–5. (PDF 980 kb)
Rights and permissions
About this article
Cite this article
Steinberg, S., Stefansson, H., Jonsson, T. et al. Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease. Nat Genet 47, 445–447 (2015). https://doi.org/10.1038/ng.3246
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.3246
- Springer Nature America, Inc.
This article is cited by
-
Gut microbiota-host lipid crosstalk in Alzheimer’s disease: implications for disease progression and therapeutics
Molecular Neurodegeneration (2024)
-
Alzheimer’s genes in microglia: a risk worth investigating
Molecular Neurodegeneration (2023)
-
CSF biomarker analysis of ABCA7 mutation carriers suggests altered APP processing and reduced inflammatory response
Alzheimer's Research & Therapy (2023)
-
Simple model systems reveal conserved mechanisms of Alzheimer’s disease and related tauopathies
Molecular Neurodegeneration (2023)
-
Step by step: towards a better understanding of the genetic architecture of Alzheimer’s disease
Molecular Psychiatry (2023)